FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1783325304> ?p ?o ?g. }

• W1783325304 endingPage "277" @default.
• W1783325304 startingPage "265" @default.
• W1783325304 abstract "The glioblastoma genome displays remarkable chromosomal aberrations, which harbor critical glioblastoma-specific genes contributing to several oncogenetic pathways. To identify glioblastoma-targeted genes, we completed a multifaceted genome-wide analysis to characterize the most significant aberrations of DNA content occurring in glioblastomas. We performed copy number analysis of 111 glioblastomas by Digital Karyotyping and Illumina BeadChip assays and validated our findings using data from the TCGA (The Cancer Genome Atlas) glioblastoma project. From this study, we identified recurrent focal copy number alterations in 1p36.23 and 4p16.3. Expression analyses of genes located in the two regions revealed genes which are dysregulated in glioblastomas. Specifically, we identify EGFR negative regulator, ERRFI1, within the minimal region of deletion in 1p36.23. In glioblastoma cells with a focal deletion of the ERRFI1 locus, restoration of ERRFI1 expression slowed cell migration. Furthermore, we demonstrate that TACC3, an Aurora-A kinase substrate, on 4p16.3, displays gain of copy number, is overexpressed in a glioma-grade-specific pattern, and correlates with Aurora kinase overexpression in glioblastomas. Our multifaceted genomic evaluation of glioblastoma establishes ERRFI1 as a potential candidate tumor suppressor gene and TACC3 as a potential oncogene, and provides insight on targets for oncogenic pathway-based therapy." @default.
• W1783325304 created "2016-06-24" @default.
• W1783325304 creator A5006813610 @default.
• W1783325304 creator A5017380326 @default.
• W1783325304 creator A5023972060 @default.
• W1783325304 creator A5034561069 @default.
• W1783325304 creator A5036636553 @default.
• W1783325304 creator A5044465742 @default.
• W1783325304 creator A5055644612 @default.
• W1783325304 creator A5064296151 @default.
• W1783325304 creator A5066433940 @default.
• W1783325304 creator A5069463284 @default.
• W1783325304 creator A5073862375 @default.
• W1783325304 creator A5073957378 @default.
• W1783325304 creator A5078430693 @default.
• W1783325304 creator A5088179286 @default.
• W1783325304 date "2010-08-08" @default.
• W1783325304 modified "2023-10-03" @default.
• W1783325304 title "Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes" @default.
• W1783325304 cites W1499660750 @default.
• W1783325304 cites W1568426705 @default.
• W1783325304 cites W1815870121 @default.
• W1783325304 cites W1880621477 @default.
• W1783325304 cites W1979483425 @default.
• W1783325304 cites W1990686151 @default.
• W1783325304 cites W1991524818 @default.
• W1783325304 cites W1999951331 @default.
• W1783325304 cites W2006240263 @default.
• W1783325304 cites W2006351736 @default.
• W1783325304 cites W2011809546 @default.
• W1783325304 cites W2011912935 @default.
• W1783325304 cites W2014089652 @default.
• W1783325304 cites W2033869679 @default.
• W1783325304 cites W2035737976 @default.
• W1783325304 cites W2036760996 @default.
• W1783325304 cites W2040827479 @default.
• W1783325304 cites W2040912449 @default.
• W1783325304 cites W2041261760 @default.
• W1783325304 cites W2042816516 @default.
• W1783325304 cites W2042921949 @default.
• W1783325304 cites W2045274471 @default.
• W1783325304 cites W2046151919 @default.
• W1783325304 cites W2050383354 @default.
• W1783325304 cites W2054290966 @default.
• W1783325304 cites W2058451329 @default.
• W1783325304 cites W2059300459 @default.
• W1783325304 cites W2062763955 @default.
• W1783325304 cites W2073963296 @default.
• W1783325304 cites W2081916198 @default.
• W1783325304 cites W2089596886 @default.
• W1783325304 cites W2091986411 @default.
• W1783325304 cites W2096061368 @default.
• W1783325304 cites W2100813299 @default.
• W1783325304 cites W2103432808 @default.
• W1783325304 cites W2107515803 @default.
• W1783325304 cites W2111679504 @default.
• W1783325304 cites W2116705584 @default.
• W1783325304 cites W2126817554 @default.
• W1783325304 cites W2129889470 @default.
• W1783325304 cites W2132438476 @default.
• W1783325304 cites W2135645995 @default.
• W1783325304 cites W2140690783 @default.
• W1783325304 cites W2142412446 @default.
• W1783325304 cites W2146878112 @default.
• W1783325304 cites W2151335185 @default.
• W1783325304 cites W2152095920 @default.
• W1783325304 cites W2156578353 @default.
• W1783325304 cites W2158441613 @default.
• W1783325304 cites W2160475600 @default.
• W1783325304 cites W2161289668 @default.
• W1783325304 cites W2162281878 @default.
• W1783325304 cites W2162391239 @default.
• W1783325304 cites W2165926532 @default.
• W1783325304 cites W2167218908 @default.
• W1783325304 cites W2169404013 @default.
• W1783325304 cites W2171217566 @default.
• W1783325304 cites W2277353858 @default.
• W1783325304 cites W4237316483 @default.
• W1783325304 doi "https://doi.org/10.18632/oncotarget.137" @default.
• W1783325304 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2992381" @default.
• W1783325304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21113414" @default.
• W1783325304 hasPublicationYear "2010" @default.
• W1783325304 type Work @default.
• W1783325304 sameAs 1783325304 @default.
• W1783325304 citedByCount "90" @default.
• W1783325304 countsByYear W17833253042012 @default.
• W1783325304 countsByYear W17833253042013 @default.
• W1783325304 countsByYear W17833253042014 @default.
• W1783325304 countsByYear W17833253042015 @default.
• W1783325304 countsByYear W17833253042016 @default.
• W1783325304 countsByYear W17833253042017 @default.
• W1783325304 countsByYear W17833253042018 @default.
• W1783325304 countsByYear W17833253042019 @default.
• W1783325304 countsByYear W17833253042020 @default.
• W1783325304 countsByYear W17833253042021 @default.
• W1783325304 countsByYear W17833253042022 @default.
• W1783325304 countsByYear W17833253042023 @default.
• W1783325304 crossrefType "journal-article" @default.

• next